← Leaderboards
Kasey C Vickers
Vanderbilt University Medical Center
$9,958,246
Attributed
$13,519,954
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,519,954 · 9
By mechanism
R01$8,171,979 · 4
P01$4,222,241 · 3
K22$745,794 · 1
R21$379,940 · 1
Top collaborators
- Rebecca Sara Cook7 shared
- Craig Lewis Duvall7 shared
- Md Jashim Uddin7 shared
- Macrae F Linton5 shared
- Amy S Major3 shared
- Dana M Brantley-Sieders1 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Macrae F Linton$20,130,632
- Khurram Nasir$3,347,111
- Amy S Major$8,135,070
- Justin Han-Je Lo$76,246
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsHigh Density LipoproteinsUntranslated RnaIn VivoIn VitroCellsGenesModificationComplexAtherosclerosisExtracellularSmall RnaMediatingPropertyBaseMicrornasLipoproteinsFunctional DisorderMessenger RnaUptakeResponseInflammationReportingCardiovascular Diseases
Grant awards (40)
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy$550,518
R01 · FY2025 · CA
Novel functions of plasminogen and its diverse cargo in blood$350,000
R01 · FY2025 · HL · contact PI
Macrophage small RNA export to HDL protects against inflammation and atherosclerosis$287,931
P01 · FY2025 · HL · contact PI
Non-Coding RNA Analytical Core$287,931
P01 · FY2025 · HL · contact PI
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy$522,993
R01 · FY2024 · CA
Macrophage small RNA export to HDL protects against inflammation and atherosclerosis$350,325
P01 · FY2024 · HL · contact PI
Novel functions of plasminogen and its diverse cargo in blood$350,000
R01 · FY2024 · HL · contact PI
Non-Coding RNA Analytical Core$186,841
P01 · FY2024 · HL · contact PI
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy$555,637
R01 · FY2023 · CA
Macrophage small RNA export to HDL protects against inflammation and atherosclerosis$389,250
P01 · FY2023 · HL · contact PI
Non-Coding RNA Analytical Core$207,600
P01 · FY2023 · HL · contact PI
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy$117,567
R01 · FY2023 · CA
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy$553,948
R01 · FY2022 · CA
Macrophage small RNA export to HDL protects against inflammation and atherosclerosis$389,250
P01 · FY2022 · HL · contact PI
Non-Coding RNA Analytical Core$207,600
P01 · FY2022 · HL · contact PI
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy$117,567
R01 · FY2022 · CA
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy$617,228
R01 · FY2021 · CA
Macrophage small RNA export to HDL protects against inflammation and atherosclerosis$389,250
P01 · FY2021 · HL · contact PI
Non-Coding RNA Analytical Core$207,600
P01 · FY2021 · HL · contact PI
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs$532,985
R01 · FY2019 · HL
HDL-microRNA Intercellular Communication in Atherosclerosis$466,923
R01 · FY2019 · HL · contact PI
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs$532,985
R01 · FY2018 · HL
HDL-microRNA Intercellular Communication in Atherosclerosis$466,923
R01 · FY2018 · HL · contact PI
Non-coding RNA & Bioinformatics Core$265,251
P01 · FY2018 · HL · contact PI
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs$532,985
R01 · FY2017 · HL
HDL-microRNA Intercellular Communication in Atherosclerosis$466,923
R01 · FY2017 · HL · contact PI
Non-coding RNA & Bioinformatics Core$265,251
P01 · FY2017 · HL · contact PI
HDL-microRNA Intercellular Communication in Atherosclerosis$466,923
R01 · FY2016 · HL · contact PI
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs$426,986
R01 · FY2016 · HL
Non-coding RNA & Bioinformatics Core$265,251
P01 · FY2016 · HL · contact PI
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs$102,625
R01 · FY2016 · HL
HDL-microRNA Intercellular Communication in Atherosclerosis$440,263
R01 · FY2015 · HL · contact PI
Non-coding RNA & Bioinformatics Core$259,618
P01 · FY2015 · HL · contact PI
Circulating microRNAs Control Cholesterol Homeostasis through hepatic mechanisms$248,598
K22 · FY2015 · HL · contact PI
HDL-mediated transfer of mircroRNA regulates autoimmunity$155,918
R21 · FY2015 · AR
HDL-mediated transfer of mircroRNA regulates autoimmunity$16,782
R21 · FY2015 · AR
Non-coding RNA & Bioinformatics Core$263,292
P01 · FY2014 · HL · contact PI
Circulating microRNAs Control Cholesterol Homeostasis through hepatic mechanisms$248,598
K22 · FY2014 · HL · contact PI
HDL-mediated transfer of mircroRNA regulates autoimmunity$207,240
R21 · FY2014 · AR
Circulating microRNAs Control Cholesterol Homeostasis through hepatic mechanisms$248,598
K22 · FY2013 · HL · contact PI